GlassScriptPhysician profile
John Michael Bacharach
NPI 1972566172
$17,889.05
in general payments reported to CMS, 2019-2025
30 companies · $861 in 2025
The $861 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,758 · 2020: $967 · 2021: $309 · 2022: $1,173 · 2023: $8,460 · 2024: $4,362 · 2025: $861.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,983 · Travel and Lodging: $3,947 · Food and Beverage: $3,752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,983.33 |
| Travel and Lodging | $3,947.13 |
| Food and Beverage | $3,751.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surmodics, INC. | $5,556.46 | 2021-2023 | Pounce Thrombectomy System, Pounce Venous Thrombectomy System |
| Contego Medical, INC | $2,912.81 | 2023-2024 | |
| Abbott Laboratories | $2,021.25 | 2020-2025 | Mitraclip, Navitor, Diamondback Peripheral |
| W. L. Gore & Associates, INC. | $1,738.43 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Medtronic Vascular, INC. | $1,019.35 | 2019-2020 | |
| Boston Scientific Corporation | $867.23 | 2019-2025 | General - Vascular Intervention, Ekosonic, Eluvia |
| Edwards Lifesciences Corporation | $729.38 | 2019-2025 | Sapien 3 Ultra Resilia, Evoque |
| Cordis US Corp. | $692.11 | 2022-2023 | Mynx Control |
| Medtronic, INC. | $528.03 | 2021-2025 | Corevalve Evolut R, Heli-Fx Endoanchor System, Mvp |
| Inspiremd LTD | $456.00 | 2024 | Cguard |
| Inari Medical, INC. | $266.17 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shockwave Medical, INC | $243.48 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Silk Road Medical, INC. | $155.15 | 2020-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Penumbra, INC. | $123.19 | 2023-2025 | Indigo System |
| Abiomed | $106.59 | 2023-2025 | Impella |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $100.40 | 2019 | |
| Cardiva Medical, INC. | $79.79 | 2024-2025 | Savvywire, Cardiva Vascade Mvp Vvcs 6-12f |
| Shape Memory Medical INC. | $55.13 | 2024 | Impede Embolization Plug |
| Reflow Medical INC | $52.17 | 2025 | |
| Asahi Intecc USA, INC. | $51.17 | 2023 | Asahi Ptca Guide Wire |
| Biosense Webster, INC. | $38.55 | 2021-2025 | Carto 3 |
| Angiodynamics, INC. | $31.61 | 2023 | Alphavac |
| Stryker Corporation | $31.11 | 2025 | Flowtriever |
| Terumo Medical Corporation | $16.90 | 2025 | Tr Band |
| Cook Medical LLC | $16.59 | 2024 | Zilver Ptx |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bacharach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.